Recently, ultrasound-induced drug delivery into the brain using bubble formulations has been developed. After the brain delivery, however, the information on pharmacokinetics of hydrophilic drugs in the brain is lacking. In this study, to clarify the time-course pharmacokinetics of hydrophilic drugs, we used a brain microdialysis method. Using ultrasound-responsive nanobubbles (bubble liposomes [BLs]) with ultrasound irradiation, two hydrophilic drugs, 5-fluorouracil (5-FU) and ascorbic acid, were delivered into the brain of mice and rats, and their time-course pharmacokinetics were evaluated with microdialysis.
Introduction

Ultrasound system and conditions
Ultrasound was irradiated to the whole brain of mice and rats by SonoPore KTAP-4000 (Nepa Gene Co., Ltd., Chiba, Japan) with 20 mm-diameter probe KP-S20 (Nepa Gene Co., Ltd.). The parameters used were as follows: frequency, 1.045 MHz; intensity, 1.0 W/cm 2 ; duty ratio, 50%; burst rate, 10 Hz; duration, 60 sec. For evaluation of the another conditions, the duration (10, 30 and 120 sec) and intensity (0.25 and 0.5 W/cm 2 ) were varied.
Brain microdialysis
Three types of mixed anesthetic agents [22] composed of 0.3 mg/kg of medetomidine, 4 .0 mg/kg of midazolam and 5.0 mg/kg of butorphanol (i.p.) were used for the mice, and ethyl carbamate (1.5 g/kg, i.p.) was used for the rats. Both mice and rats were fixed with a stereotaxic instrument SR-5R (Narishige Scientific Instrument Lab., Tokyo, Japan). The microdialysis probe A-I-4-02 (Eicom Corporation, Kyoto, Japan) was inserted into the mouse brain (at a coordinate of A, +2.2 mm; L, +1.0 mm; H, -3.0 mm from the bregma), and the microdialysis probe CX-I-10-04 (Eicom Corporation) was inserted into the rat brain (at a coordinate of A, +0.6 mm; L, +5.0 mm; H, -7.0 mm from the bregma). Each microdialysis probe consists of regenerated cellulose membrane with a molecular weight cut-off of 50,000 Da, and recovery ratios from standard solution of 8.17 ± 0.67% (5-FU, A-I-4-02 probe, n=3) and 16.2 ± 0.4% (ascorbic acid, CX-I-10-04 probe, n=3). Artificial cerebrospinal fluid (aCSF) was used as perfusate at a flow rate of 2 µL/min.
Experimental schedules
The experimental schedule is shown in Scheme 1. Mice and rats were stabilized for 2 h after insertion of the microdialysis probes into the brain. Then drugs and BLs were injected i.v. (100 mg/kg of 5-FU and 7.4 mg/kg of BLs) or i.p. (50 mg/kg of ascorbic acid), and immediately the brain was subjected to ultrasound. Drug administration, BLs administration and ultrasound irradiation was performed within 5 min in this order. The time at which the ultrasound irradiation ended was set to 0 min, and the dialysates were collected for 300 min in intervals of 15 min (0-180 min) and 30 min (180-300 min).
For evaluation for another conditions of BLs administration and ultrasound irradiation, 100 mg/kg of 5-FU was used. The following three parameters were examined: the dose of BLs administration, the duration of the ultrasound irradiation and the ultrasound intensity. When one parameter was changed, the other two parameters 
HPLC conditions for determination of 5-FU
The dialysates from the mouse brain were applied to the high-performance liquid chromatography (HPLC) system for the determination of 5-FU [23] . The HPLC system consisted of an LC-10ADVP pump (Shimadzu Corporation, Kyoto, Japan), a 7725i injector (Rheodyne Inc., Cotati, CA, USA) with a 20 µL sample loop, a Wakopak Handy-ODS column (150 mm × 4.6 mm, i.d.; Wako Pure Chemical Industries, Ltd.), an SPD-10AVP ultraviolet detector (detection wavelength, 266 nm; Shimadzu Corporation).
5-FU was separated in 10 mM sodium acetate buffer (pH 4.0) at a flow rate of 0.7 mL/min.
HPLC conditions for determination of ascorbic acid
The dialysates from the rat brain were doubly dissolved and applied to two HPLC systems for measuring concentration and antioxidant capacity of ascorbic acid. Ascorbic acid concentrations in the dialysates were determined with an HPLC system consisted of an LC-10AT pump (Shimadzu Corporation), a 7125 injector (Rheodyne Inc.) with a 20 µL sample loop, a Shodex Asahipak NH2-50 4E column (250 × 4.6 mm, i.d.; Showa Denko K.K., Tokyo, Japan), an SPD-10AVP ultraviolet detector (detection wavelength, 254 nm; Shimadzu Corporation). Ascorbic acid was separated in a mixture of 20% sodium phosphate buffer and 80% acetonitrile at a flow rate of 1.0 mL/min.
HPLC conditions for SMFIA method
The antioxidant capacity of ascorbic acid in the dialysates was measured using the SMFIA method. An HPLC system for the SMFIA was designed as described in a previous report [19] . The antioxidant capacity was presented as the percentages of the scavenged chemiluminescences in the reaction of luminol and reactive oxygen species.
Statistical analysis
Statistical analysis was performed using JMP ® Pro version 11.2.0 (SAS Institute Inc., Cary, NC, USA). P<0.05 was defined as significantly different.
Results
Physicochemical properties of BLs
The mean diameter and zeta-potential of BLs were 330 ± 47.0 nm and -2.45 ± 1.51 mV, respectively (n=3).
Time-course evaluation of ultrasound-induced drug delivery into the brain
Time-course evaluation with 5-FU
We first confirmed whether microdialysis is useful for evaluation of ultrasound-induced drug delivery into the brain. Figure 1a Table 1 .
Time-course evaluation with ascorbic acid
To support the result obtained with 5-FU, we examined the time-course profiles using a different species, rats, and a different drug, ascorbic acid. Figure 2a shows the timecourse profiles of ascorbic acid concentration in the dialysates perfused through the rat brain. In the group treated with both BLs administration and ultrasound irradiation, the peak concentration of ascorbic acid (2.01 ± 0.71 µg/mL) was observed from 15-30 min after ultrasound irradiation. The AUC in the group with BLs administration and ultrasound irradiation (152 ± 43.1 µg･min/mL) was significantly (P<0.01) higher than the AUCs in the other groups (the group without any stimulation, 17.0 ± 16.0 µg･ min/mL; the group with BLs administration, 11.0 ± 5.18 µg･min/mL; the group with ultrasound irradiation, 9.50 ± 2.25 µg･min/mL) (Figure 2b ). Other pharmacokinetic parameters of ascorbic acid in the brain are shown in Table 2 .
Relationship between the pharmacokinetics and pharmacodynamics:
Antioxidant capacity of dialysates from the rat brain Figure 3 shows the time-course profiles of the antioxidant capacity in dialysates perfused through the rat brain. In the group administered BLs and ultrasound irradiation, the peak antioxidant capacity (76.9 ± 5.02%) was observed from 15-30 min. The other groups showed antioxidant capacity of less than 10%.
Effect of BLs and ultrasound for targeting 5-FU delivery into the brain
Dose of BLs administration
The effect of BLs on ultrasound-induced drug delivery into the brain was examined by at BLs doses of 0.925, 1.85, 3.7, and 7.4 mg/kg in terms of their lipids. Data are expressed as the time-course profiles from 0 to 180 min (Figure 4a) , and the peak concentrations of 5-FU were 1.02 ± 0.04 µg/mL (0.925 mg/kg group), 1.15 ± 0.19 µg/mL (1.85 mg/kg group), 1.43 ± 0.18 µg/mL (3.7 mg/kg group), and 1.89 ± 0.26 µg/mL (7.4 mg/kg group). The AUC from the time-course profile of the 7.4 mg/kg group (65.9 ± 20.1 µg･min/mL) was significantly (P<0.05) higher than that from the 0.925 mg/kg group (27.2 ± 7.31 µg･min/mL) (Figure 4b) .
Duration of ultrasound irradiation
The effect of ultrasound on drug delivery into the brain was examined by varying the duration and intensity of the ultrasound irradiation. The duration of ultrasound irradiation was set to 10, 30, 60, and 120 sec, and the time-course profiles of 5-FU in each group was examined (Figure 5a ). The group with 60 sec of ultrasound irradiation showed the highest peak concentration (1.63 ± 0.26 µg/mL) followed by the groups irradiated for 30 sec (1.46 ± 0.51 µg/mL), 120 sec (1.40 ± 0.60 µg/mL), and 10 sec (1.03 ± 0.55 µg/mL). The AUCs from the time-course profiles for each group were not significantly different (Figure 5b ).
Ultrasound intensity
The ultrasound intensities were set to 0.25, 0.5, and 1 W/cm 2 . Figure 6a 
Discussion
In this study, we evaluated the detailed pharmacokinetic profiles of two hydrophilic drugs in the brain after delivery with BLs and ultrasound irradiation. First, we used 5-FU as a model drug and observed its time-course brain delivery in mice. The highest peak concentration of 5-FU in the dialysate was observed when BLs administration and ultrasound irradiation were combined (Figure 1a) . The AUC from the time-course profile of the group subject to BLs administration and ultrasound irradiation was significantly (P<0.05) higher than the AUCs from the other groups (Figure 1b) . We also evaluated the relationship between the pharmacokinetics and pharmacodynamics for ascorbic acid using microdialysis in the rat brain. The time-course profiles of the antioxidant capacity in the dialysates (Figure 3) corresponded to those where the concentration of ascorbic acid was varied (Figure 2a) . Moreover, the result from the time-course profiles versus ascorbic acid concentration (Figure 2a ) supports the result with 5-FU ( Figure 1a) ; both 5-FU and ascorbic acid concentrations reached a peak within 30 min after ultrasound irradiation and then rapidly decreased. The difference of pharmacokinetics between 5-FU and ascorbic acid with ultrasound irradiation is not clear still (Figures 1 and 2) . Thus, the pharmacokinetics ( Figure 2 the most relevant factor involved in the BBB disruption [24] . In their report, the concentration of Evans blue dye in brain sections increased in a manner dependent on the volume of the microbubbles. Although the diameter is different between the microbubbles and the BLs, our result is corresponding the report by Song et al.
Therefore, the brain microdialysis would be a useful method to evaluate the pharmacokinetics of the hydrophilic drugs after the brain delivery using bubble formulations and ultrasound irradiation.
On the other hand, when the duration of the ultrasound irradiation was varied from 10 to 120 sec, the peak concentrations in the time-course profiles of 5-FU did not correspond to the durations of ultrasound irradiation (Figure 5a ). The AUCs of the groups exposed to 10 to 60 sec of ultrasound irradiation increased stepwise, while the AUC of the group exposed to 120 sec was smaller than the group exposed to 60 sec.
Additionally, there were no significant differences between the AUCs (Figure 5b ).
When the ultrasound intensity was varied from 0.25 to 1 W/cm 2 , the time-course profiles for 5-FU (Figure 6a ) and the AUCs (Figure 6b ) of the three groups were in accordance with each other. These results may not correspond to other reports of the brain delivery using focused ultrasound [2, 3, 5, 7, 25] . Because we used unfocused ultrasound and sonicated the whole brain, almost all of the BLs in the blood vessel of the brain might have destroyed, and changing conditions of unfocused ultrasound might have little effect for 5-FU delivery into the brain. In the further study using the unfocused ultrasound, therefore, the conditions of the ultrasound irradiation are needed to be considered to control the drug delivery into brain.
In the field of ultrasound-induced drug delivery into the brain, magnetic resonance imaging (MRI) [2, 8] or dye staining [9] are commonly used for time-course evaluations of the brain delivery. These methods use contrast agents such as gadolinium or Evans blue, not drugs themselves. The problem is that the pharmacokinetics of these contrast agents must be different from the targeted drugs from the view point of protein binding rate, retentivity in the blood, and molecular weight. In this study, however, we showed that the time-course evaluation of the brain delivery of the hydrophilic drugs themselves was possible. The microdialysis probes inserted may have disrupted the BBB. Nevertheless, 5-FU and ascorbic acid without any stimulations were little delivered into the brain (Figures 1 and 2) . Thus, we think that histopathological problems may have not influenced on our evaluation results. Additionally, this is the first report to clarify the time-course pharmacokinetics of hydrophilic drugs in the brain after delivering with bubble formulations and ultrasound irradiation. We believe that the evaluation method with microdialysis enables the analysis for pharmacokinetics of more and more hydrophilic drugs after delivered into the brain because microdialysis recovers drugs themselves.
In this study, however, the results indicated that the drug continuance remaining in the brain was short and the drug concentration rapidly decreased as shown in the time-course profiles (Figures 1 and 2 ). Drugs delivered into the brain may flow out to the cerebrospinal fluid by the bulk flow. In addition, this phenomenon may also be explained by the fact that the BBB was not closed immediately [2] , and drugs in the brain may have leaked out into the blood vessels. This hypothesis corresponds with the report by Negishi et al. that proposes the BBB might be open to some extent for up to 24 h after the ultrasound irradiation under their experimental conditions [9] . If the BBB closes immediately, drugs are expected to remain in the brain for a longer period.
Additionally, it is necessary to control the BBB opening after drug delivery into the brain for safety and effectiveness. We believe that microdialysis enables the easy collection of more detailed information under various conditions of bubble formulations and ultrasound. Using the evaluation method with microdialysis, we will attempt to minimise the duration of the BBB opening for safe and efficient brain delivery of drugs using focused and/or unfocused ultrasound in the future.
Conclusions
We succeeded in clarifying the time-course pharmacokinetics of the two hydrophilic drugs in the brain after the delivery with the ultrasound-responsive BLs and ultrasound irradiation using mice and rats. 
